“This document represents a collective effort to refine and advance the standards of care in STEMI management," according to one cardiologist behind the project. 

While the initial purchase price was $600 million, the final amount could reach approximately $1.7 billion if certain milestones are met. V-Wave's Ventura Interatrial Shunt System for HFrEF has gained considerable interest in recent years, and Johnson & Johnson was an early investor in the technology back in 2016.

CMS is now accepting public comments on this topic until Nov. 2. A final decision is expected by July 2025.

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

A new study found cumulative radiation exposure of 16 mSv to red bone marrow can cause an increased rate of some hematological malignancies.

The Accelerating Kids' Access to Care Act would expand Medicaid access for pediatric patients so that it covers interventional cardiologists outside of their home states.

LVOT obstruction remains a significant complication of TMVR, making the long-term safety and effectiveness of the LAMPOON technique a hot topic in interventional cardiology.

Early data suggest the J-Valve transcatheter heart valve could help care teams avoid a rare, but often fatal TAVR complication when treating high-risk patients.